Eurofins Proxy Laboratories B.V. Pharmadox Healthcare Ltd.

Poland

All drugs from this manufacturer

  • ICATIBANT ZENTIVA

    The medicinal product is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and in adolescents and children aged 2 years and older.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant acetate 30 31.38-35.52 mg/3.0 ml

    ATC: B06AC02

  • IDANUZ

    The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and adolescents and children aged 2 years and older.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant 10 mg/ml

    ATC: B06AC02